v3.26.1
Subsequent Events (Details) - USD ($)
$ in Millions
6 Months Ended
Jul. 21, 2026
Jul. 16, 2026
Jul. 13, 2026
Jun. 30, 2026
Subsequent Event [Line Items]        
Convertible preferred stock       61
Common stock held       $ 30.0
Comprehensive loss       $ 0.4
Stock Dividends [Member]        
Subsequent Event [Line Items]        
Ownership percentage       4.90%
Stock Splits [Member]        
Subsequent Event [Line Items]        
Ownership percentage       19.90%
Fundamental Transaction [Member]        
Subsequent Event [Line Items]        
Ownership percentage       19.90%
Pre-Financing [Member]        
Subsequent Event [Line Items]        
Purchase an aggregate       392,791
Post-Financing [Member]        
Subsequent Event [Line Items]        
Purchase an aggregate       351,201
Nonredeemable Convertible Preferred Stock [Member]        
Subsequent Event [Line Items]        
Issuance of shares       61
Convertible preferred stock       4,644,977
Nonredeemable Convertible Preferred Stock [Member] | Post-Financing [Member]        
Subsequent Event [Line Items]        
Purchase an aggregate       254,462
Pre-Merger Company Shareholders [Member] | Pre-Financing [Member]        
Subsequent Event [Line Items]        
Company shareholders held approximately       11.27%
Kira shareholders [Member] | Pre-Financing [Member]        
Subsequent Event [Line Items]        
Company shareholders held approximately       88.73%
Kira shareholders [Member] | Post-Financing [Member]        
Subsequent Event [Line Items]        
Company shareholders held approximately       49.86%
PIPE Investors [Member] | Post-Financing [Member]        
Subsequent Event [Line Items]        
Company shareholders held approximately       43.46%
Financing [Member] | Post-Financing [Member]        
Subsequent Event [Line Items]        
Company shareholders held approximately       6.68%
Subsequent Event [Member]        
Subsequent Event [Line Items]        
Convertible preferred stock 4,655,951      
Aggregate gross proceeds $ 132.0      
Upfront payment     $ 12.0  
Aggregated value     108.5  
Net sales     $ 350.0  
Subsequent Event [Member] | Kira Pharmaceuticals [Member] | Merger Agreement [Member]        
Subsequent Event [Line Items]        
Issuance of shares   5,195,009    
Subsequent Event [Member] | Non-Voting Convertible Preferred Stock [Member]        
Subsequent Event [Line Items]        
Issuance of shares   9,906,591    
Convertible preferred stock   0.0001